M&A Deal Summary

Baxter International Acquires CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets

On July 29, 2021, Baxter International acquired life science company CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets from Artivion for 61M USD

Acquisition Highlights
  • This is Baxter International’s 4th transaction in the Life Science sector.
  • This is Baxter International’s 16th largest (disclosed) transaction.
  • This is Baxter International’s 13th transaction in the United States.
  • This is Baxter International’s 1st transaction in Georgia.

M&A Deal Summary

Date 2021-07-29
Target CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets
Sector Life Science
Buyer(s) Baxter International
Sellers(s) Artivion
Deal Type Divestiture
Deal Value 61M USD

Target

CryoLife - PerClot Polysaccharide Hemostatic System Certain Assets

Kennesaw, Georgia, United States
CryoLife's PerClot Polysaccharide Hemostatic System Certain Assets are indicated for use in surgical procedures (except neurological and ophthalmic) or injuries as an adjunct hemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical. CryoLife's PerClot Polysaccharide Hemostatic System Certain Assets are based in Kennesaw, Georgia.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Baxter International

Deerfield, Illinois, United States

Category Company
Founded 1931
Sector Medical Products
Employees60,000
Revenue 14.8B USD (2023)
DESCRIPTION
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.

Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.


DEAL STATS #
Overall 19 of 20
Sector (Life Science) 4 of 4
Type (Divestiture) 6 of 6
State (Georgia) 1 of 1
Country (United States) 13 of 14
Year (2021) 1 of 2
Size (of disclosed) 16 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-02 sanofi-aventis U.S.

United States

Seprafilm Adhesion Barrier provides prevention products, hemostats, and sealants are important tools surgeons use to manage intraoperative bleeding and reduce adhesions.

Buy $350M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-02 Hill-Rom

Chicago, Illinois, United States

Hill-Rom manufactures and provides medical technologies and related services for the health care industry. Hill-Rom offers patient care systems, safe mobility and handling solutions, and non-invasive therapeutic products for various acute and chronic medical conditions, medical equipment rentals, surgical products, and information technology solutions. Hill-Rom was founded in 1915 and is based in Chicago, Illinois.

Buy $12.4B

Seller(S) 1

SELLER

Artivion

Kennesaw, Georgia, United States

Category Company
Founded 1984
Sector Medical Products
Employees1,500
Revenue 354M USD (2023)
DESCRIPTION

Artivion is a manufacturer, processor, and distributor of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. Artivion was incorporated in 1984 and is based in Kennesaw, Georgia.


DEAL STATS #
Overall 4 of 4
Sector (Life Science) 1 of 1
Type (Divestiture) 4 of 4
State (Georgia) 1 of 1
Country (United States) 4 of 4
Year (2021) 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-02 Ascyrus Medical

Boca Raton, Florida, United States

Ascyrus Medical LLC is a developer of the Ascyrus Medical Dissection Stent (AMDS™), aortic arch remodeling device used for the treatment of acute Type A aortic dissections. Ascyrus Medical is based in Boca Raton, Florida.

Buy $200M